Statistics
Total Visits
Views | |
---|---|
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer(legacy) | 130 |
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer(legacy) | 69 |
Total Visits per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer | 2 | 5 | 3 | 3 | 0 | 10 | 3 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 78 |
China | 9 |
Netherlands | 8 |
France | 6 |
Germany | 5 |
Vietnam | 5 |
Australia | 4 |
United Kingdom | 2 |
Sweden | 2 |
Iran | 1 |
Top City Views
Views | |
---|---|
Ashburn | 27 |
Fairfield | 12 |
Rotterdam | 8 |
New York | 7 |
Cambridge | 6 |
Hanoi | 5 |
Dearborn | 3 |
Beijing | 2 |
Boardman | 2 |
Adelaide CBD | 1 |